siRNA treatment reduces triglycerides in clients along with rare problem

.INVESTIGATION EMPHASIZE.19 September 2024.

Plozasiran reduced triglyceride degrees through 80% as well as reduced the risk of pancreatitis in patients with constant chylomicronemia, with or without a genetic prognosis.